Quote | Repare Therapeutics Inc. (NASDAQ:RPTX)
Last: | $3.30 |
---|---|
Change Percent: | 0.32% |
Open: | $3.09 |
Close: | $3.30 |
High: | $3.5 |
Low: | $3.09 |
Volume: | 203,900 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | Repare Therapeutics Inc. (NASDAQ:RPTX)
Debiopharm ( www.debiopharm.com ), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases , and Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage p...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, and Debiopharm ( www.debiopharm.com ), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards...
Message Board Posts | Repare Therapeutics Inc. (NASDAQ:RPTX)
Subject | By | Source | When |
---|---|---|---|
I believe we going to break 15 on | Gator44 | investorshub | 06/08/2022 3:12:26 PM |
I believe we going hit 15 this week | ElusTrade | investorshub | 06/05/2022 4:00:24 PM |
Not alone bought on the news sold Friday | akamaii | investorshub | 06/04/2022 3:55:49 PM |
$RPTX: We just busted-through to a "LUCKY THIRTEEN | Just-Keep-Trying | investorshub | 06/03/2022 7:55:23 PM |
$RPTX: Something is UP!!!! INDEED, a shinny-new GREEN | Just-Keep-Trying | investorshub | 06/03/2022 7:46:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Repare Therapeutics Inc. Company Name:
RPTX Stock Symbol:
NASDAQ Market:
Debiopharm ( www.debiopharm.com ), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases , and Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage p...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, and Debiopharm ( www.debiopharm.com ), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company’s upcoming annu...